Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Accorto Regulatory Solutions joins GINN to Further Tobacco Harm Reduction Mission 2024-09-04 23:00
TraceLink's Magnum Release of its Opus Platform Will Revolutionize Supply Chain Management by Enabling All Businesses to Digitalize their End-to-End Supply Networks 2024-09-04 22:00
Regenity Biosciences Receives Regulatory Approval for Collagen Dental Membrane in China After First-of-its-Kind Breakthrough Clinical Study 2024-09-04 21:00
Phesi Receives Frost & Sullivan's Global Enabling Technology Leadership Award for Revolutionizing Clinical Development with Its Trial Accelerator Platform 2024-09-04 21:00
LakeShore Biopharma Announces Leadership Transitions 2024-09-04 20:00
LakeShore Biopharma Announces Leadership Transitions 2024-09-04 20:00
21st.BIO obtains self-affirmed GRAS status for its precision fermented beta-lactoglobulin: 21st.BIO customers can now enter the U.S. market with their own production using 21st.BIO technology 2024-09-04 15:47
HKBU develops Chinese medicine for ulcerative colitis approved by National Medical Products Administration for clinical trial 2024-09-04 15:13
Innovent Receives Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α Bispecific Antibody Fusion Protein) as Monotherapy for Advanced Melanoma 2024-09-04 08:00
IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances 2024-09-04 06:57
Frost Radar™ Positions 14 Top Growth & Innovation Leaders in Global Healthcare Data Interoperability 2024-09-04 01:45
Immune Phenotyping Identified as Promising Predictive Biomarker by Lunit AI in Biliary Tract Cancer - New publication in CCR 2024-09-03 21:00
Biostar Announces Completion of Patient Recruitment for US Phase 1 Clinical Study of Utidelone Capsule 2024-09-03 20:00
Skyline Therapeutics' Novel Gene Therapy SKG1108 Receives FDA Orphan Drug Designation for Retinitis Pigmentosa 2024-09-03 18:00
GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDA 2024-09-03 15:59
Caliway Announces the Initiation of Subject Recruitment in CBL-514 Phase 2b Study for Dercum's Disease 2024-09-03 15:18
Neusoft Education Actively Advances Education-Healthcare-Wellness Integrated Development, Starting a New Horizon for High-Quality Development 2024-09-03 08:50
Seegene and Springer Nature Launch 'Nature Awards MDx Impact Grants' to Innovate Syndromic PCR Diagnostic Assays 2024-09-02 21:00
Simcere Zaiming collaborates with TargetRx to introduce a third-generation ALK inhibitor 2024-09-02 20:24
Frost & Sullivan Released Report: "BiBo Pharma: A Global CDMO Leading in Advanced Biopharmaceutical Manufacturing Technologies" 2024-09-02 17:20
1 30 31 32 33 34 962